Description

The fund primarily directs its investments toward equity securities. A minimum of 80% of its total assets is consistently allocated to companies whose core operations involve the development, manufacturing, or distribution of products and services vital to the health and medical fields. The portfolio may include both U.S. and international issuers. Investment decisions are made through a meticulous fundamental analysis, evaluating aspects like each company's financial robustness, its competitive position within its industry, and the overarching market and economic climate.